Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Open in API
Filings indexed 968 across all filing types
Latest filing 2025-01-23 Declaration of Voting R…
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
BIOS_PR_2024_novembre_Denominator_FR.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a regulatory announcement from BioSenic regarding the total number of voting rights and shares as of November 30, 2024, following the issuance of new shares. This type of disclosure is a standard regulatory requirement for listed companies to inform the market about changes in capital structure and voting rights. It fits the 'Share Issue/Capital Change' category as it details the issuance of new shares and the resulting impact on the capital and voting rights.
2025-01-23 French
BIOS_PR_2024_December_Denominator_EN.pdf
Share Issue/Capital Change Classification · 100% confidence The document is a press release titled 'Information on the total number of voting rights and shares'. It explicitly mentions the issuance of new shares and provides a table detailing the change in share capital and voting rights (denominator) as required by Article 15 of the Belgian law on the publication of major shareholdings. This is a standard regulatory disclosure for capital changes and share issuance, fitting the 'Share Issue/Capital Change' category.
2025-01-23 English
BIOS_PR_2024_décembre_Denominator_FR.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a regulatory announcement from BioSenic regarding the total number of voting rights and shares as of December 31, 2024. It explicitly references Article 15 of the Belgian Law of May 2, 2007, concerning the disclosure of major shareholdings. This type of filing is a standard regulatory requirement for listed companies to update the market on their capital structure and share count, which falls under the category of Share Issue/Capital Change (SHA) as it details the issuance of new shares and the resulting change in the total number of voting rights.
2025-01-23 French
BIOS_PR_2024_December_Denominator_EN.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly labeled as a "PRESS RELEASE – REGULATED INFORMATION" and its primary content details the "Information on the total number of voting rights and shares on December 31, 2024." It specifically mentions the publication requirement under Article 15 of the Belgian law regarding major shareholdings and provides a detailed breakdown of the change in the total number of shares and voting rights due to a new issuance (40,000,000 new shares). This type of announcement, focusing on changes in the total share count or voting rights, directly corresponds to a notification about capital structure changes or share issuance. Among the provided codes, 'SHA' (Share Issue/Capital Change) is the most appropriate fit, as the core subject is the change in the number of shares and voting rights resulting from an issuance. It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a major shareholding notification (MRQ) which typically reports changes by an external shareholder crossing a threshold.
2025-01-23 English
BIOS_PR_2024_décembre_Denominator_FR.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE" (Press Release – Regulated Information) dated January 23, 2025. The core content explicitly details the "Information relative au nombre total de droits de vote et d'actions au 31 décembre 2024" (Information relative to the total number of voting rights and shares as of December 31, 2024). It provides a breakdown of the total share capital, the number of voting shares, and potential shares issuable upon exercise of warrants or conversion of bonds, referencing Belgian law requirements for significant shareholding declarations. This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory filing, often related to capital structure changes or major shareholding notifications. Since the document is a formal announcement detailing a change in the denominator (total voting rights) following an issuance of new shares, it directly relates to capital structure changes or major shareholding updates. Given the options, 'Share Issue/Capital Change' (SHA) is highly relevant due to the 40,000,000 new shares issued. However, the primary focus is the resulting total voting rights count, which is a key component of Major Shareholding Notification (MRQ) or a general regulatory filing. Since the document explicitly states the issuance of new shares and the resulting total voting rights, it fits best under Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA). Because it is a formal, periodic disclosure of the total voting rights count following an event (new issuance), and it is presented as a press release/regulated information, it is a specific regulatory disclosure. Given the context of reporting the total number of shares and voting rights, which is often required when thresholds are crossed or capital changes occur, SHA is the most precise fit for reporting the outcome of the share issuance. If it were purely a notification of someone else crossing a threshold, MRQ would apply. Since the company is announcing the result of its own issuance, SHA is appropriate. Alternatively, as a general regulated information press release, RNS could be used, but SHA is more specific to the content.
2025-01-23 French
BIOS_PR_2025-01-23_Transparency Notification_CGE_EN.pdf
Major Shareholding Notification Classification · 100% confidence The document is a press release announcing a 'transparency notification' regarding a change in major shareholdings. It explicitly mentions the crossing of a 5% threshold by Capital Grand Est SAS, which is a classic 'Major Shareholding Notification' (MRQ). The document provides the details of the notification, the reason for the crossing, and the transaction date, fitting the definition of a major shareholding disclosure.
2025-01-23 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.